المؤلفون: Tolcher AW; Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, USA. atolcher@start.stoh.com, Mita A, Lewis LD, Garrett CR, Till E, Daud AI, Patnaik A, Papadopoulos K, Takimoto C, Bartels P, Keating A, Antonia S

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2008 Nov 10; Vol. 26 (32), pp. 5198-203. Date of Electronic Publication: 2008 Sep 29.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Antineoplastic Agents/*pharmacokinetics , Apoptosis/*drug effects , Imidazoles/*administration & dosage , Imidazoles/*pharmacokinetics , Microtubule-Associated Proteins/*antagonists & inhibitors , Naphthoquinones/*administration & dosage , Naphthoquinones/*pharmacokinetics , Neoplasm Proteins/*antagonists & inhibitors , Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Agents/adverse effects ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Imidazoles/adverse effects ; Infusions, Intravenous ; Inhibitor of Apoptosis Proteins ; Male ; Maximum Tolerated Dose ; Microtubule-Associated Proteins/metabolism ; Middle Aged ; Naphthoquinones/adverse effects ; Neoplasm Proteins/metabolism ; Neoplasms/metabolism ; Neoplasms/pathology ; Pilot Projects ; Survivin ; Treatment Outcome

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.